|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 12/28/09 Codexis Inc S-1 37:5.9M RR Donnelley/FA |
Document/Exhibit Description Pages Size
1: S-1 Registration Statement (General Form) HTML 1.99M
2: EX-3.1 Seventh Amended and Restated Certificate of HTML 118K
Incorporation
3: EX-3.3 Amended and Restated Bylaws of the Registrant, as HTML 148K
Currently in Effect
4: EX-4.2 Fifth Amended and Restated Investor Rights HTML 210K
Agreement
5: EX-4.3 Form of Warrant to Purchase Shares of Common Stock HTML 49K
6: EX-4.4 Warrant to Purchase Shares of Common Stock HTML 62K
7: EX-4.5 Form of Warrant to Purchase Shares of Series D HTML 54K
Preferred Stock - as of 5/25/2006
8: EX-4.6 Form of Warrant to Purchase Shares of Series D HTML 67K
Preferred Stock - as of 9/28/2007
9: EX-4.7 Warrant to Purchase Shares of Common Stock Issued HTML 80K
to Alexandria Equities, LLC
10: EX-4.8 Registration Rights Agreement HTML 73K
25: EX-10.10 2002 Stock Plan, as Amended, and Form of Stock HTML 220K
Option Agreement
26: EX-10.12A Offer Letter - Alan Shaw HTML 25K
27: EX-10.12B Change in Control Agreement - Alan Shaw HTML 103K
28: EX-10.13A Offer Letter Agreement - Robert S. Beuil HTML 27K
29: EX-10.13B Change in Control Agreement - Robert S. Breuil HTML 45K
30: EX-10.13C Separation Agreement - Robert S. Breuil HTML 62K
31: EX-10.14A Offer Letter Agreement - Douglas T. Sheehy HTML 33K
32: EX-10.14B Chang in Control Agreement - Douglas T. Sheehy HTML 103K
33: EX-10.15 Offer Letter Agreement - David L. Anton HTML 27K
34: EX-10.16 Employment Contract - Peter Seufer-Wasserthal HTML 41K
35: EX-10.18 Form of Indemnification Agreement HTML 55K
11: EX-10.1A Loan and Security Agreement HTML 314K
12: EX-10.1B First Amendment to Loan and Security Agreement HTML 45K
13: EX-10.2A License Agreement HTML 152K
14: EX-10.2B Amendment No. 1 to the Maxygen License HTML 77K
15: EX-10.2C Amendment No. 2 to the Maxygen License HTML 18K
16: EX-10.2D Amendment No. 3 to the Maxygen License HTML 75K
17: EX-10.2E Side Letter - Dated February 18, 2005. HTML 17K
18: EX-10.2F Side Letter - Dated September 11, 2007 HTML 20K
19: EX-10.2G Side Letter - Dated September 24, 2007 HTML 20K
20: EX-10.8A Lease Agreement HTML 305K
21: EX-10.8B Amendment to Lease Agreement - June 1, 2004 HTML 23K
22: EX-10.8C Amendment to Lease Agreement - March 9, 2007 HTML 71K
23: EX-10.8D Amendment to Lease Agreement - March 31, 2008 HTML 149K
24: EX-10.9 Master Security Agreement HTML 151K
36: EX-21 List of Subsidiaries HTML 13K
37: EX-23.1 Consent of Independent Public Accounting Firm HTML 12K
| Offer Letter Agreement - David L. Anton |
Exhibit 10.15
 |
Codexis, Inc. 200 Penobscot Drive Tel: 650.980.5600 Fax: 650.298.5449 |
David Anton, Ph. D.
[Address]
Dear Dave:
On behalf of Codexis, I’m delighted to confirm our verbal offer of full-time employment as Vice President, Bioindustrial Research and Development, reporting to Alan Shaw, President & CEO.
This offer is contingent on our receiving positive employment references.
Your employment is subject to proof of your legal right to work in the United States, and to your completing the United States Citizenship and Immigration Service Employment Eligibility Verification Form I-9.
Compensation
If you accept this offer and begin employment with Codexis, you will receive an initial salary of $19,583 per month (equivalent to $235,000 per year), payable in periodic installments on our regular paydays. You will also be a participant in the Codexis Executive Incentive Compensation Plan (prorated to your actual start date). For 2008, your target will be 25% of your annualized base salary, which will be awarded at the discretion of the Codexis Board of Directors based on the Company’s performance relative to its corporate objectives for the year. You must be employed by Codexis on the date that the bonus is paid in order to be eligible for the bonus.
Signing Bonus
Codexis will pay you a signing bonus of $10,000 (less applicable withholding). This bonus is contingent upon your starting work with Codexis on or before March 24, 2008.
Stock Options
Subject to approval by the Codexis Board of Directors, you will be granted an option to purchase 100,000 shares of stock at an exercise price equal to the fair market value of the shares on the date the option is granted. The shares subject to the Option will vest one fourth or 25% on the first anniversary of your employment start date and thereafter will vest as to 1/48 of the shares subject to the Option per month for the following 36 months until the option is 100% vested. Your stock options will be subject to the terms of the Codexis Inc. 2002 Stock Plan and will be conditioned on your acceptance of an appropriate stock option agreement.
Employee Benefits
As a fulltime employee, you will be eligible for the Codexis employee benefit plans, including medical, dental, vision, long and short-term disability plans, life insurance, a 401(k) savings plan, and our flexible time off plan that allows fulltime employees to accrue 20 days of flexible time off each year of employment.
Bringing Life to Chemistry
|
|
Codexis, Inc. 200 Penobscot Drive Tel: 650.980.5600 Fax: 650.298.5449 |
Relocation
Codexis will offer relocation assistance per the attached Summary.
Other Terms and Conditions of Employment
All employment with Codexis is at will. “Employment at will” means that you are free to resign from your employment at any time, for any reason or no reason at all, with or without cause and with or without notice. Similarly, Codexis may terminate your employment at any time for any legal reason, with or without cause and with or without notice. By accepting this offer of employment, you agree that your employment is at will, and acknowledge that no one, other than the President of Codexis or the Chairman of the Board of Directors of Codexis has the authority to promise you, either orally or in writing, anything to the contrary. Any such agreement must be in writing and signed by both you and such individual to be effective.
Employment with any other entity or for yourself in competition with Codexis, or any affiliate or subsidiary of Codexis is not permitted. If you want to take an outside job, paid or unpaid, you should discuss the outside opportunity with your manager and the Human Resources Department in advance so that we can determine if any actual or potential conflict of interest exists.
During the course of your employment, you may create, develop or have access to confidential information belonging to Codexis, including trade secrets and proprietary information, such as technical and scientific research and/or protocols, customer and supplier information, business plans, marketing plans, unpublished financial information, designs, drawings, innovations, inventions, discoveries, specifications, software, source codes, and personnel information. You agree that as a condition of your employment with Codexis, you will sign and comply with the Codexis Confidential Information, Secrecy and Invention Agreement.
Arbitration of Disputes
You agree that, except as described below, any dispute relating to your employment or the termination of your employment with Codexis will be finally settled by binding arbitration in Palo Alto, California before a neutral arbitrator of the American Arbitration Association (“AAA”) under its National Rules for the Resolution of Employment Disputes. Claims subject to arbitration include, but are not limited to, claims under Title VII of the Civil Rights Act of 1964 (as amended) and other civil rights statutes of the United States, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the Employee Retirement Income Security Act of 1974, the California Fair Employment and Housing Act, the California Labor Code, and any other federal, state or local statute or regulation, and the common law of contract and tort. However, this agreement to arbitrate will not apply to claims (a) for workers’ compensation, (b) for unemployment compensation or (c) injunctive relief arising out of or related to misappropriation of trade secrets or misuse or improper disclosure of confidential information, unfair competition or breach of any non-competition or non-solicitation agreement between you and Codexis.
You understand that by this agreement, you and Codexis are waiving your respective rights to trial by jury, and that judgment upon any arbitration award may be entered in any court having
Bringing Life to Chemistry
|
|
Codexis, Inc. 200 Penobscot Drive Tel: 650.980.5600 Fax: 650.298.5449 |
jurisdiction of the matter. Any controversy or claim subject to arbitration will be waived and forever barred if arbitration is not initiated within one year after the date the controversy or claim first arose, or if statutory rights are involved, within the time limit established by the applicable statute of limitations.
With regard to statutory claims, you and Codexis will have the same remedies available in arbitration as those available had the claim been filed in a court of law, including, where authorized by statute, compensatory and punitive damages, injunctive relief and attorneys’ fees. Although Codexis will pay all costs of the AAA and the arbitrator, you agree to pay all costs you would otherwise be required to pay were your claims litigated in a court of law, such as costs of your attorney, deposition transcripts and expert witness fees and expenses.
The terms described in this letter replace all prior agreements, understandings and promises between Codexis and you concerning the terms and conditions of your employment with Codexis.
Dave, we’re pleased to extend this offer of employment to you, and hope that your association with Codexis will be mutually successful and rewarding. Please indicate your acceptance of this offer by signing this letter below and faxing it to me (at 650-421-8145) by February 15, 2008. We look forward to welcoming you aboard!
| Sincerely, | ||
| Codexis, Inc. | ||
| By: | /s/ Andy Danforth | |
| Andy Danforth | ||
| VP, Human Resources | ||
| Codexis, Inc. | ||
I understand and agree to the foregoing terms and conditions of employment with Codexis.
| /s/ David L. Anton, Ph. D. |
| David L. Anton, Ph. D. |
| 2/15/2008 | March 24, 2008 | |||||||||||
| Date / | Start Date |
Attachment
Bringing Life to Chemistry
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 12/28/09 | None on these Dates | ||
| 3/24/08 | ||||
| 2/15/08 | ||||
| 2/12/08 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 Codexis, Inc. 10-K 12/31/23 121:13M 2/27/23 Codexis, Inc. 10-K 12/31/22 121:15M 2/28/22 Codexis, Inc. 10-K 12/31/21 111:16M 3/01/21 Codexis, Inc. 10-K 12/31/20 110:14M |